secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2025-11-14T23:59:59+00:00
Accession:  0001193125-25-283139
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health issues $10.81M secured note to Streeterville Capital; $8M held as collateral
--------------------------------------------------------------------------------

- Net proceeds of $10M after $800K OID and $10K transaction expenses; interest 8% p.a., maturity 36 months.
- $8M deposited in restricted account at Lakeside Bank as collateral; release allowed for excess over declining requirement.
- Lender can redeem up to $600K/month starting month 12; mandatory prepayment of 25% of upfront IP licensing fees.
- Note secured by subsidiary guaranty (JAGX Holdings) and pledge of all its membership interests; strict negative covenants on additional debt and equity.
- Proceeds at Company's discretion, including repayment of $6M June 2025 convertible bridge notes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312525283139/0001193125-25-283139-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312525283139/d930413d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-283139

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer